Cargando…
What, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria
While safe and efficacious COVID-19 vaccines have achieved high coverage in high-income settings, roll-out remains slow in sub-Saharan Africa. By April 2022, Nigeria, a country of over 200 million people, had only distributed 34 million doses. To ensure the optimal use of health resources, cost-effe...
Autores principales: | Ruiz, Francis J., Torres-Rueda, Sergio, Pearson, Carl A. B., Bergren, Eleanor, Okeke, Chinyere, Procter, Simon R., Madriz-Montero, Andres, Jit, Mark, Vassall, Anna, Uzochukwu, Benjamin S. C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032534/ https://www.ncbi.nlm.nih.gov/pubmed/36963054 http://dx.doi.org/10.1371/journal.pgph.0001693 |
Ejemplares similares
-
Assessing the impacts of COVID-19 vaccination programme’s timing and speed on health benefits, cost-effectiveness, and relative affordability in 27 African countries
por: Liu, Yang, et al.
Publicado: (2023) -
The invisible hands in policy making: A qualitative study of the role of advocacy in priority setting for maternal and child health in Nigeria
por: Okeke, Chinyere, et al.
Publicado: (2023) -
Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders’ capacity, needs, policy areas of demand and perspectives in Nigeria
por: Uzochukwu, Benjamin S. C., et al.
Publicado: (2020) -
Analysing key influences over actors’ use of evidence in developing policies and strategies in Nigeria: a retrospective study of the Integrated Maternal Newborn and Child Health strategy
por: Mbachu, Chinyere O., et al.
Publicado: (2016) -
Antihypertensive medicine use differs between Ghana and Nigeria
por: Hollingworth, Samantha A., et al.
Publicado: (2022)